Remus Shareholders Approve Migration to NSE and BSE Main Boards
Remus Pharmaceuticals Ltd 路 Annual General Meeting 路 08 Oct 2026, 12:45 am
Remus Shareholders Approve Migration to NSE and BSE Main Boards Remus Pharmaceuticals Limited announced that its shareholders approved a special resolution via postal ballot to migrate listing and trading of equity shares from NSE Emerge to the main boards of NSE and BSE. The remote e-voting concluded on 6th Oct'26 with 100% of the 238,600 valid public votes cast in favor and zero against, fulfilling Regulation 277 SEBI ICDR requirements. Promoter and promoter group entities did not participate in the vote, and the resolution passed with the requisite majority.
Original exchange filing (PDF)
More announcements from Remus Pharmaceuticals Ltd
- Remus Pharmaceuticals Limited has informed the Exchange about Transcript 路 06 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange about Audio Recording 路 04 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange about Investor Presentation 路 04 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange regarding a media release dated November 03, 2026 路 03 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 07-Nov-2026. 路 03 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on November 03, 2026, declared Interim Dividend of Rs. 1.00 per equity share. 路 03 Nov 2026
- Remus Pharmaceuticals Limited has submitted to the Exchange Outcome of Board Meeting held on November 03, 2026 路 03 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange about Schedule of meet 路 29 Oct 2026
